Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The epithelial–mesenchymal transition at the crossroads between metabolism and tumor progression
The transition between epithelial and mesenchymal phenotype is emerging as a key
determinant of tumor cell invasion and metastasis. It is a plastic process in which epithelial …
determinant of tumor cell invasion and metastasis. It is a plastic process in which epithelial …
The role of miRNAs in regulating gene expression networks
AM Gurtan, PA Sharp - Journal of molecular biology, 2013 - Elsevier
MicroRNAs (miRNAs) are key regulators of gene expression. They are conserved across
species, expressed across cell types, and active against a large proportion of the …
species, expressed across cell types, and active against a large proportion of the …
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator
A great hallmark of breast cancer is the absence or presence of estrogen receptors ERα and
ERβ, with a dominant role in cell proliferation, differentiation and cancer progression. Both …
ERβ, with a dominant role in cell proliferation, differentiation and cancer progression. Both …
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids
K Lõhmussaar, O Kopper, J Korving, H Begthel… - Nature …, 2020 - nature.com
High-grade serous ovarian cancer (HG-SOC)—often referred to as a “silent killer”—is the
most lethal gynecological malignancy. The fallopian tube (murine oviduct) and ovarian …
most lethal gynecological malignancy. The fallopian tube (murine oviduct) and ovarian …
HMGA2 is a driver of tumor metastasis
A Morishita, MR Zaidi, A Mitoro… - Cancer …, 2013 - aacrjournals.org
The non-histone chromatin-binding protein HMGA2 is expressed predominantly in the
mesenchyme before its differentiation, but it is also expressed in tumors of epithelial origin …
mesenchyme before its differentiation, but it is also expressed in tumors of epithelial origin …
Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation
S Zhu, Y Wu, X Zhang, S Peng, H **ao, S Chen, L Xu… - Molecular Therapy, 2023 - cell.com
Radiofrequency heat ablation is an ideal radical treatment for hepatocellular carcinoma
(HCC). However, insufficient radiofrequency ablation (IRFA) could lead to high recurrence of …
(HCC). However, insufficient radiofrequency ablation (IRFA) could lead to high recurrence of …
Transforming growth factor-β in tumour development
CB Trelford, L Dagnino… - Frontiers in Molecular …, 2022 - frontiersin.org
Transforming growth factor-β (TGFβ) is a ubiquitous cytokine essential for embryonic
development and postnatal tissue homeostasis. TGFβ signalling regulates several biological …
development and postnatal tissue homeostasis. TGFβ signalling regulates several biological …
HMGA2–FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer
J Dong, R Wang, G Ren, X Li, J Wang… - Clinical Cancer …, 2017 - aacrjournals.org
Purpose: Chemoresistance is the main cause of treatment failure in cancer and is
associated with distant metastases and epithelial-to-mesenchymal transition (EMT). This …
associated with distant metastases and epithelial-to-mesenchymal transition (EMT). This …
The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186
Y Wang, F Chen, M Zhao, Z Yang, J Li, S Zhang… - Journal of Biological …, 2017 - jbc.org
The long noncoding RNA highly up-regulated in liver cancer (HULC) is aberrantly elevated
in hepatocellular carcinoma (HCC), and this up-regulation is crucial for HCC pathogenesis …
in hepatocellular carcinoma (HCC), and this up-regulation is crucial for HCC pathogenesis …
Roles of microRNAs in ovarian cancer tumorigenesis: two decades later, what have we learned?
AA Alshamrani - Frontiers in oncology, 2020 - frontiersin.org
Ovarian cancer is one of the top gynecological malignancies that cause deaths among
females in the United States. At the molecular level, significant progress has been made in …
females in the United States. At the molecular level, significant progress has been made in …